Zofran Lawsuits


Morning sickness is common during pregnancy, affecting more than half of all pregnant women. In most situations, morning sickness can be managed conservatively, however in 10-15% of cases, pregnant women receive treatment with various pharmaceutical drugs. However, because morning sickness manifests early in pregnancy, with the onset between three and eight weeks of pregnancy and peak symptoms in weeks seven to twelve in most cases, drug treatment often coincides with the period during which the fetus is most susceptible to teratogenic effects. Among the drugs available for the treatment of morning sickness, Zofran, or in its generic form known as Ondansetron, has become the most frequently used prescription morning sickness drug in the United States. In fact, between 2004 and 2008, almost 3% of women who were enrolled in the Slone Epidemiology Center birth defects study reported having received Zofran during the first trimester. Overall, Zofran was the fifth most frequently used prescription medication overall by pregnant women.

Despite the prevalent use of Zofran during pregnancy, data that support its safety for the fetus are limited. To date, there is very little research detailing whether or not Zofran birth defects can be one of the Zofran side effects resulting when pregnant women use Zofran to treat morning sickness. While Zofran certainly has shown its ability to prevent nausea in pregnant women, the startling lack of correlation to Zofran use and any potential Zofran birth defect studies is truly frightening for any pregnant women struggling with the decision to either suffer through the ill effects of morning sickness or seek treatment with Zofran.

Recently, there has been evidence linking Zofran birth defects to the use of Zofran during pregnancy to treat morning sickness. This has become the basis for Zofran lawsuits handled by Zofran attorneys at NGK Law. The Zofran birth defect lawyers at NGK Law have examined the various studies that have come out linking Zofran birth defects to the use of Zofran during pregnancy. These Zofran birth defect studies include studies in journals such as a December 2014 article in Reproductive Toxicology Journal, several studies regarding a Danish database examining potential Zofran birth defects, and more recent studies examining Zofran birth defects, including a recent study published in the prestigious New England Journal of Medicine.

Zofran birth defect lawsuits are focusing on the fact that the FDA classifies Zofran as a “pregnancy category B” medication, which means animal studies have not found evidence of a risk to pregnant women babies, but no one knows if it is safe. Zofran birth defect lawsuits allege that the manufacturers of Zofran knew, or should have known, that the use of Zofran by pregnant women for morning sickness was a risk to the fetus that simply should not be taken. Zofran birth defect lawsuits argue that as a result of this knowledge of potential Zofran birth defects, the manufacturers of Zofran, and the FDA in addition, should have had a much stronger warning regarding the use of Zofran during pregnancy, due to the increased risk of Zofran birth defects.

The Zofran birth defect attorneys at NGK Law are pursuing Zofran birth defect lawsuits for women whose children suffered birth defects, including Zofran heart defects, Zofran cleft pallet, Zofran brain defects, Zofran cardiac defects, and other various Zofran birth defects after mothers took Zofran during pregnancy. In particular, the Zofran birth defect lawyers at NGK Law are interested in pursuing Zofran birth defect lawsuits for women that took Zofran to treat morning sickness during the first trimester, or the first three months of their pregnancy. It is during the first trimester that the risk for Zofran birth defects is the most great. As indicated above, during the first three months of the pregnancy, there are numerous developmental stages of a fetus, which put them at a greater sensitivity and susceptibility to Zofran birth defects, given this important stage of the fetus’ development.

Obviously, this is the argument of the Zofran birth defect lawsuits by the Zofran birth defect lawsuit attorneys at NGK Law. NGK Law has, for many years, pursued birth defect lawsuits for women who took Lexapro, Zoloft, and Celexa while pregnant and gave birth to children that suffered from birth defect injuries. In those situations, the Lexapro birth defects, Zoloft birth defects, and Celexa birth defects, have been very similar to the birth defects that the Zofran birth defect attorneys at NGK Law have been seeing with the use of Zofran.

If you used Zofran while you were pregnant and gave birth to a child that suffered from Zofran birth defects, contact the Zofran birth defect lawsuit attorneys at NGK Law immediately at 1-844-5-NGKLAW, or 1-844-564-5529, or fill out our online form to speak with one of the NGK Law Zofran attorneys immediately.